Skip to content

Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy

Pregnancy Outcomes and Vitamin D Level Among Vitamin D Supplementation During Pregnancy : A Double-blind Randomized Placebo Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04591847
Enrollment
60
Registered
2020-10-19
Start date
2020-10-19
Completion date
2021-08-31
Last updated
2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Outcome Among Vitamin D Supplementation During Pregnancy

Keywords

Vitamin D, 25-hydroxyvitamin D, Pregnancy, Infant

Brief summary

To compared pregnancy outcome (Serum vitamin D level in mother and infant , preeclampsia rate, preterm birth rate, Infant birth weight, Infant length , APGAR score) between pregnant women who were given vitamin D supplementation and pregnant women who were given placebo

Interventions

Vitamin D2 20000IU 1 tab oral weekly

DRUGPlacebo drug

Placebo drugs 1 tab oral weekly

Sponsors

Department of Medical Services Ministry of Public Health of Thailand
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Thai female * Singleton pregnancy * Age at 18 years old or more * Gestational age at 18-22 weeks * Accept to enroll

Exclusion criteria

* Pregnant women who not planned to delivery at Rajavithi hospital * Abnormal kidney function * Use antiepileptic drugs , or vitamin D supplementation * Allergy to vitamin D * Who were diagnosed as vitamin D deficiency

Design outcomes

Primary

MeasureTime frameDescription
Serum 25-OH vitamin D level in pregnant womenAt delivery timemeasure in nmol/L
Serum 25-OH vitamin D level in umbilicalcord bloodAt delivery timemeasure in nmol/L

Secondary

MeasureTime frameDescription
Infant APGAR scoreAt delivery timeMeasure at delivery time score 10/10 Appearance : Cyanotic, pale all over = 0 , Peripheral cyanotic only = 1 , Pink = 2 Pulse : 0 bpm = 0 , \<100 = 1, 100-140 = 2 Grimace : no response to stimulation = 0 , Grimace(facial movement ,weak cry) = 1 Cry when stimulated = 2 Activity (tone) : floppy = 0 , Some flexion = 1 , Well flexed and resisting extension = 2 Respiration : Apnoeic = 0 , Slow irregular = 1 , Strong cry = 2
PreeclampsiaDuring pregnancy until deliveryMeasure by clinical and laboratory of preeclampsia ้high blood pressure ( \>= 140/90 mmHg) with proteinuria (UPCI \> 0.3 mg/dL or Urine protein 24 hours \> 300 mg) or in absence of proteinuria with new onset of any of the following * thrombocytopenia : Platelet count less than 100,000 x 10\^9 /L * Serum creatinine \> 1.1 mg/dL or doubling of the serum creatinine * Elevated liver transaminases to twice normal * Pulmonary edema * New onset headache unresponsive to medication * Visual symptom
Infant lengthAt delivery timemeasure in centimeters
Infant birth weightAt delivery timemeasure in kilograms
Preterm birthAt delivery timeDelivery before GA 37 weeks

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026